Why Are Psychiatrists Interested
The risks rise even further the longer the gap, with up to 22% higher risk of a major cardiovascular event after two years off therapy
Nausea, vomiting, and other gastrointestinal symptoms are common, particularly when starting or increasing the dose and in T1D trials, these rates were similar to those seen in T2D and obesity trials
The macrophage shift is one reason why GLP-1 receptor agonists show benefit across such diverse autoimmune conditions
As described in the Introduction, previous studies with little or no antibody specificity control experiments reported GLP-1R immunoreactivity primarily in glial cells, and to a lesser degree in neurons 24,25,26,27,28
Its also more affordable, explains Dr Kansal